Skip to content

The Changes of CD4+T Lymphocyte Subsets in Septic Patients

The Role of CD4+T Lymphocyte Subsets in Cell Immunity in Patients With Sepsis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01494389
Enrollment
Unknown
Registered
2011-12-19
Start date
2011-08-31
Completion date
2012-03-31
Last updated
2011-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, SIRS(Systemic Inflammatory Response Syndrome)

Keywords

CD4+T lymphocyte subsets, sepsis, immunoparalysis

Brief summary

The purpose of this study is to explore the value of CD4+T lymphocyte subsets in cell immunity in the patients with sepsis.There are immunoparalysis in septic patients,the important player is the change of CD4+T lymphocyte,this immunoparalysis state contribute to the illness progress and outcome. Comprehend the change regularity of septic patients' cell immunity can guide fiter and correcter treatment.

Interventions

None listed

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female aged 18 years old and over; * Fulfilled at least two criteria of systemic inflammatory response syndrome (a) core temperature higher than 38 °C or lower than 36 °C (b)respiratory rate above 20/min, or PCO2 below 32 mmHg (c) pulse rate above 90/min, and (d) white blood cell count greater than 12,000/μl or lower than \< 4,000/μl or less than 10% of bands. * Clinically suspected infection;

Exclusion criteria

* were under 18 years of age; * were refused by the patients or his/her familiality; * were suffering from acquired immunodeficiency syndrome,virlhepatitis,autoimmune diseases and hematology; * use medicine which can affect immune system,such as Glucocorticoid and Immunosuppressant * died within 24h after being taken into the ICU, or refused to get involved in the study, or gave up treatment during the period of observation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026